Cell and gene therapy companies develop advanced treatments that modify, replace or engineer cells and genetic material to treat disease. The field is one of the fastest-growing areas of biotechnology and precision medicine.
This category includes companies working on:
Browse 162 UK cell and gene therapy companies below.
University of Oxford GMP facility for clinical-grade biologics
The Clinical BioManufacturing Facility is the University of Oxford's GMP-licensed manufacturing facility, producing biological investigational medicinal products for early-phase clinical trials. The facility holds an MHRA Manufacturer's Authorisation for Investigational Medicinal Products and manufactures viral vector…
Inhaled lentiviral gene therapies for rare respiratory diseases
AlveoGene is a biotechnology company developing inhaled gene therapies for rare respiratory disorders. It uses a lentiviral vector platform engineered to deliver therapeutic genes efficiently to the cells lining the airways and lungs. Its lead programme targets alpha-1 antitrypsin deficiency, an inherited condition…